FundingWatcher
Home / Startups / Top health care startups / Health care startups in China

Health care startups in China

Updated 16 Nov 2026

Reset
Health care startups in China
One-time CSV
  • 3,459 funded companies, 2,131 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care~china-500a.csv3,459 rows × 18 columns
CompanyCityLast roundAmountDate
HypershellShenzhenSeries B$50.0M2026-05-18
EnjosimShanghaiSeries B$30.1M2026-11-02
AusperBioHangzhouSeries C$120.0M2026-08-27
Tianhu TechnologyMinhangSeries A$29.0M2026-07-13
Degron TherapeuticsShanghaiSeries A$40.0M2026-05-14
Weikaier Pharmaceutical TechnologyNanjingSeries C$29.6M2026-06-02
MindRank AIShanghaiSeries B$52.0M2026-07-08
Hyperway PharmChengduSeries B$14.9M2026-10-15

8 rows of the CSV in 5 of its 18 columns.

3,459
Startups
$57.8B
Total raised
525
Funded in the last 12 months
$7.0B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 3,459
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Huasaiboman Medical Cell Biology Huasaiboman Medical Cell Biology provides new cell therapy technologies and solutions as a biotechnology company. Biotech Qingdao Shi Series B $30.0M 2026-11-09 $30.0M ASBV 11 to 50 2019
Tushen Zhihe Tushen Zhihe provides artificial intelligence protein design services. Artificial intelligence Minhang Seed $1.4M 2026-11-09 $1.5M Wuxi Capital, CHENGMEI VENTURES 11 to 50 2023
Enjosim Enjosim researches, manufactures, and sells self-delivery systems for biomacromolecule pharmaceuticals. Biotech Shanghai Series B $30.1M 2026-11-02 $30.1M Luminous Ventures (former Lightspeed China Partners), Jiayuan Capital 51 to 100 2021
Hyperway Pharm Hyperway Pharm conducts pharmaceutical research, development, and production. Health care Chengdu Series B $14.9M 2026-10-15 $56.8M Si Chuan Venture Capital, Chengdu High-tech Ceyuan Capital, Huaige Capital +1 51 to 100 2019
Aibo Medical Robot Aibo Medical Robot researches and develops robots for vascular interventional surgery. Hardware Shenzhen Series A $14.1M 2026-10-15 $33.0M Lenovo Capital and Incubator Group (LCIG), CDH Investments, Long Hill Capital +2 2020
Haimikang Intelligence Haimikang Intelligence develops brain-computer interfaces and exoskeleton medical products. Health care Putuo Seed $1.4M 2026-10-15 $1.4M New Access Capital 51 to 100 2020
Bluesail Surgical Bluesail Surgical develops surgical instruments for cardiovascular treatments. Biotech Shanghai Series B $104.5M 2026-09-23 $245.4M Huagai Capital, Linkong Private Equity Fund Management, Linqu County High-Tech Industrial Investment 101 to 250 2020
Barty Medical Barty Medical provides hospital healthcare services to patients. Health care Hangzhou Series D $29.5M 2026-09-23 $46.7M Shenzhen Guozhong Venture Capital Management, Sinowisdom, Sunz Fund 101 to 250 2015
Nutshell Therapeutics Nutshell Therapeutics discovers small-molecule drugs using insights from protein dynamics. Artificial intelligence Shanghai Series C $40.0M 2026-09-15 $75.2M Matrix Partners China, Source Code Capital, Northern Light Venture Capital +1 51 to 100 2013
QL Biopharma QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. Biotech Beijing Series C $44.7M 2026-09-14 $173.7M Chengdu Science and Technology Venture Capital, TF Capital, Lichen Capital +1 101 to 250 2018
Medefa Medefa uses synthetic biology to mass-produce novel PHA biomaterials. Biotech Zhuhai Series B $14.9M 2026-09-02 $16.3M Motianshi Touzi, Taiping Innovation 11 to 50 2019
Kossel Medical Kossel Medical develops and manufactures vascular interventional devices and clinical system solutions. Health care Suzhou Series C $59.5M 2026-09-01 $103.0M Fortune Venture Capital, Suzhou International Development Venture Capital, Ming Bioventures +1 501 to 1,000 2013
Yuce Biotechnology Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. Biotech Suzhou Series B $7.4M 2026-08-31 $22.4M Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 101 to 250 2019
AusperBio AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. Biotech Hangzhou Series C $120.0M 2026-08-27 $357.0M Qiming Venture Partners, BioVenture, Hankang Capital +1 51 to 100 2019
MileBot Robotics MileBot Robotics develops robots for medical and healthcare applications. Artificial intelligence Shenzhen Series B $14.9M 2026-08-26 $14.9M Lenovo Capital and Incubator Group (LCIG), Share Capital, Shangyuan Capital 101 to 250 2016
Leadinno Medical Valley Leadinno Medical Valley produces medical devices that regulate neurological functions. Health care Beijing Series B $29.7M 2026-08-17 $90.3M Fortune Venture Capital, Cowin Capital, Taiyu Investment +2 10,001 or more 2016
Hongxin Biology Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. Biotech Shenzhen Series B $14.0M 2026-08-13 $14.0M Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group 11 to 50 2021
Phil Rivers Technology Phil Rivers Technology provides AI solutions for pharmaceutical research and development. Artificial intelligence Beijing Series A $29.6M 2026-08-05 $57.3M Insight Capital 51 to 100 2015
Kai Medtech Kai Medtech markets and sells vascular intervention medical devices. Health care Minhang Series D $73.9M 2026-07-28 $105.3M Shenzhen Capital Group, Wuxi Capital, Hengxu Capital +1 51 to 100 2019
Layerwave Bio Layerwave Bio develops diagnostic instrument reagents and biomedical research instruments. Biotech Daxing Series B $13.8M 2026-07-28 $13.8M IDG Capital, Addor Capital, Hotung Venture Capital 51 to 100 2020
Diyingjia Technology Diyingjia Technology develops artificial intelligence software for medical imaging and treatment applications. Artificial intelligence Beijing Series C $3.0M 2026-07-28 $32.3M IDG Capital, Legend Capital, Microsoft Accelerator 11 to 50 2017
Delova Biotech Delova Biotech develops treatments for pain management. Biotech Qixia Series C $88.6M 2026-07-22 $109.8M Legend Capital, Peakview Capital, Hyfinity Investments +1 51 to 100 2017
Tianhu Technology Tianhu Technology uses computational chemistry and artificial intelligence to design new drug molecules. Artificial intelligence Minhang Series A $29.0M 2026-07-13 $54.2M Qiming Venture Partners, GSR United Capital, 3E Bioventures 11 to 50 2021
MindRank AI MindRank AI develops artificial intelligence platforms to discover and develop small molecule drugs. Artificial intelligence Shanghai Series B $52.0M 2026-07-08 $101.0M Green Pine Capital Partners, Huagai Capital, Sherpa Healthcare Partners +1 11 to 50 2020
Sonosemi Medical Sonosemi Medical provides medical devices for vascular interventional diagnosis and treatment. Health care Shenzhen Series B $27.3M 2026-07-08 $27.3M Eight Roads Ventures, Co-Stone Venture Capital, Guangzhou Yuexiu Industrial Investment Fund +1 101 to 250 2020
Prime Lifescience Prime Lifescience develops a big data platform for life sciences research and analysis. Biotech Hangzhou Series A $14.7M 2026-06-30 $44.5M Qiming Venture Partners, Qiji Investment, Ennovation Ventures 11 to 50 2021
Lingtai Krypton Biotechnology Lingtai Krypton Biotechnology develops lncRNA drugs to treat human diseases. Biotech Shuangliu Series A $13.7M 2026-06-26 $13.7M Legend Capital, Guosheng Capital, Firefly Haoyue 11 to 50 2021
Artivila Therapeutics Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. Artificial intelligence Shenzhen Series A $14.7M 2026-06-23 $53.3M Highlight Capital, Med-Fine Capital, Hike Capital +2 11 to 50 2018
MoleculeMind MoleculeMind combines artificial intelligence with biotechnology to develop new drugs and biological solutions. Artificial intelligence Haidian Series A $86.0M 2026-06-17 $114.6M Shenzhen Capital Group, Lenovo Capital and Incubator Group (LCIG), Sense Capital 51 to 100 2022
Haimai Medical Haimai Medical develops tissue engineering and regenerative medicine technologies. Health care Suzhou Series A $14.3M 2026-06-12 $14.3M IDG Capital, Shanghai Biomedical Industrial Equity Investment Fund, Tahoe Venture +1 51 to 100 2021

Table 1. Health care startups in China: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 3,459.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 CORXEL Pharmaceuticals CORXEL Pharmaceuticals develops medicines for underserved patients. Biotech Shanghai Series D $287.0M 2026-01-22 $451.8M Leaps by Bayer, RTW Investments 51 to 100 2019
2 New Radiomedicine Technology New Radiomedicine Technology supplies medical isotopes in China. Biotech Chengdu Series E $145.4M 2026-04-03 $330.6M Chengdu Science and Technology Venture Capital 101 to 250 2016
3 AusperBio AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. Biotech Hangzhou Series C $120.0M 2026-08-27 $357.0M Qiming Venture Partners, BioVenture, Hankang Capital +1 51 to 100 2019
4 Full-Life Technologies Full-Life Technologies develops, produces, and commercializes medicines for cancer therapy. Biotech Shanghai Series D $109.0M 2026-05-18 $337.3M Sky9 Capital, Chengwei Capital, Prosperity7 Ventures +1 51 to 100 2021
5 D3 Bio D3 Bio develops and registers medicines as a biotechnology company. Biotech Wuxi Shi Series B $108.0M 2025-12-09 $370.0M Matrix Partners China, Boyu Capital, Medicxi 1 to 10 2020
6 Bluesail Surgical Bluesail Surgical develops surgical instruments for cardiovascular treatments. Biotech Shanghai Series B $104.5M 2026-09-23 $245.4M Huagai Capital, Linkong Private Equity Fund Management, Linqu County High-Tech Industrial Investment 101 to 250 2020
7 Surgerii Technology Surgerii Technology develops minimally invasive surgical robots. Hardware Haidian Series D $100.0M 2025-12-31 $100.0M Shunwei Capital, SDIC Venture Capital, Shanghai Biomedical Industrial Equity Investment Fund +1 11 to 50 2014
8 Delova Biotech Delova Biotech develops treatments for pain management. Biotech Qixia Series C $88.6M 2026-07-22 $109.8M Legend Capital, Peakview Capital, Hyfinity Investments +1 51 to 100 2017
9 Zenitar Zenitar conducts drug research and biomedical technology industrialization. Biotech Chengdu Series C $86.0M 2026-01-12 $155.7M Si Chuan Venture Capital, Chengdu High-tech Ceyuan Capital, New Value Capital 51 to 100 2019
10 MoleculeMind MoleculeMind combines artificial intelligence with biotechnology to develop new drugs and biological solutions. Artificial intelligence Haidian Series A $86.0M 2026-06-17 $114.6M Shenzhen Capital Group, Lenovo Capital and Incubator Group (LCIG), Sense Capital 51 to 100 2022

Table 2. Health care startups in China: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Qiming Venture Partners Venture capital firm Shanghai, China 32 1% 8 AusperBio, Tianhu Technology, Prime Lifescience
2 Matrix Partners China Venture capital firm Beijing, China 23 1% 3 Nutshell Therapeutics, Alioth, D3 Bio
3 Shenzhen Capital Group Venture capital firm Nanshan, China 21 1% 3 Kai Medtech, MoleculeMind, MAXVAX
4 IDG Capital Private equity firm Beijing, China 20 1% 6 Layerwave Bio, Diyingjia Technology, Haimai Medical
5 BioVenture Venture capital firm Suzhou, China 19 1% 5 AusperBio, Degron Therapeutics, AccuPulse
6 CDH Investments Private equity firm Kowloon City, Hong Kong 16 0% 2 Aibo Medical Robot, HemaCell
7 Legend Capital Venture capital firm Beijing, China 16 0% 5 Diyingjia Technology, Delova Biotech, Lingtai Krypton Biotechnology
8 Lenovo Capital and Incubator Group (LCIG) Venture capital firm Beijing, China 14 0% 4 Aibo Medical Robot, MileBot Robotics, Zhonghe Gene
9 Puhua Capital Venture capital firm Hangzhou, China 14 0% 1 Yuce Biotechnology
10 Northern Light Venture Capital Venture capital firm Beijing, China 13 0% 3 Nutshell Therapeutics, HemaCell, Jingwei Shida
11 Fortune Venture Capital Venture capital firm Shenzhen, China 12 0% 4 Kossel Medical, Leadinno Medical Valley, RoboCT
12 ZhenFund Entrepreneurship program Beijing, China 12 0%
13 Sherpa Healthcare Partners Venture capital firm Beijing, China 11 0% 1 MindRank AI
14 Shanghai Biomedical Industrial Equity Investment Fund Venture capital firm Huangpu, China 11 0% 4 Haimai Medical, AccuPulse, Surgerii Technology
15 Taiyu Investment Venture capital firm Beijing, China 11 0% 4 Leadinno Medical Valley, Novamab, Tingsheng Technology

Table 3. Health care startups in China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 1,203 35% $28.5B
Software 417 12% $6.7B
Hardware 198 6% $1.6B
Artificial intelligence 183 5% $3.7B
Commerce 89 3% $2.3B
Education 57 2% $233.3M
Fintech 46 1% $2.0B
Energy 13 0% $93.9M
Cybersecurity 6 0%

Table 4. Health care startups in China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 5 0% $153K
Seed 1,143 33% $787K
Series A 1,172 34% $4.4M
Series B 664 19% $14.4M
Series C 309 9% $21.8M
Series D+ 166 5% $46.2M

Table 5. Health care startups in China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Beijing 449 13%
Shanghai 447 13%
Shenzhen 303 9%
Hangzhou 295 9%
Suzhou 214 6%
Haidian 155 4%
Guangzhou 144 4%
Nanjing 119 3%
Chengdu 97 3%
Wuhan 64 2%
Minhang 61 2%
Xuhui 52 2%

Table 6. Health care startups in China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 15 3% $226.0M
October 2026 29 6% $553.8M
September 2026 31 6% $874.0M
August 2026 32 6% $504.0M
July 2026 41 8% $767.7M
June 2026 38 7% $417.4M
May 2026 40 8% $715.4M
April 2026 35 7% $540.7M
March 2026 51 10% $407.8M
February 2026 35 7% $242.9M
January 2026 82 16% $776.7M
December 2025 65 12% $713.5M
November 2025 31 6% $250.7M

Table 7. Health care startups in China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 429 12% $6.0B
2025 459 13% $4.1B
2024 305 9% $2.0B
2023 350 10% $2.9B
2022 262 8% $3.8B
2021 245 7% $10.0B

Table 8. Health care startups in China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 246 7%
2020 to 2022 638 19%
2015 to 2019 1,250 37%
2010 to 2014 793 23%
Before 2010 470 14%

Table 9. Health care startups in China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 265 10%
11 to 50 1,062 39%
51 to 100 543 20%
101 to 250 426 16%
251 to 500 214 8%
501 to 1,000 100 4%
1,001 to 5,000 72 3%
5,001 to 10,000 9 0%
10,001 or more 10 0%

Table 10. Health care startups in China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in China are on the list?
3,459, in the file dated 16 November 2026. 525 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 3,459 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups in China: 3,459 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care startups in China by funding stage

Other sectors in China

Health care startups elsewhere

Cite: FundingWatcher, 3,459 funded health care companies in China, 16 November 2026. https://fundingwatcher.com/startups/health-care/china-500a/